Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Resistance to thyroid hormone beta (RTHβ) is a rare and usually dominantly inherited syndrome caused by mutations of the thyroid hormone receptor β gene (THRB). In severe cases, it is rarely challenging to control manifestations using daily therapeutic replacement of thyroid hormone. CASE PRESENTATION: The present case study concerns an 8-year-old Japanese girl with a severe phenotype of RTH (TSH, fT3, and fT4 were 34.0 mU/L, >25.0 pg/mL and, >8.0 ng/dL, respectively), caused by a novel heterozygous frameshift mutation in exon 10 of the thyroid hormone receptor beta gene (THRB), c.1347-1357 del actcttccccc : p.E449DfsX11. RTH was detected at the neonatal screening program. At 4 years of age, the patient continued to suffer from mental retardation, hyperactivity, insomnia, and reduced resting energy expenditure (REE), despite daily thyroxine (L-T4) therapy. Every-other-day high-dose liothyronine (L-T3) therapy improved her symptoms and increased her REE, without thyrotoxicosis. CONCLUSION: In a case of severe RTH, every-other-day L-T3 administration enhanced REE and psychomotor development, without promoting symptoms of thyrotoxicosis. Every-other-day L-T3 administration may be an effective strategy for the treatment of severe RTH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferrara, A. M., Onigata, K., Ercan, O., Woodhead, H., Weiss, R. E., & Refetoff, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2642 · Cited by 110 · cited 1×
“Patients with biallelic mutations of THRB also develop a severe phenotype [4, 5].”
Background
Research works printed but not linked: 11
- Refetoff S, Bassett JH, Beck-Peccoz P, Bernal J, Brent G, Chatterjee K, et al. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid. 2014;24:407–9. · DOI
- Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormome. Endocr Rev. 1993;14:348–99.
- Wu SY, Cohen RN, Simsek E, Senses DA, Yar NE, Noel J, et al. A Novel thyroid hormone receptor-β mutation that fails to bind nuclear receptor corepressor in apatien as an apparent cause of severe, predominantly a pituitary resistance to thyroid hormome. J Clin Endocrinol Metab. 2006;19:1887–95.
- Ono S, Schwartz ID, Mueller O, Root AW, Usala SJ, Beruc BB. Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J Clin Endocrinol Metab. 1991;73:990–4. · DOI · Paper page
- Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ, et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med. 1993;328:997–1001. · DOI · Paper page
- Weiss RE, Stein MA, Refetoff S. Behavioral effects of liothyronine (L-T3) in children with attention deficit hyperactivity disorder in the presence and absence of resistance to thyroid hormone. Thyroid. 1997;7:389–93. · DOI · Paper page
- Kato J, Koike A, Hoshimoto-Iwamoto M, Nagayama O, Sakurada K, Sato A. Yet al. Relation between oscillatory breathing and cardiopulmonary function during exercise in cardiac patients. Circ J. 2013;77:661–6. · DOI
- Lam CW, On-kei Chan A, Tong SF, Shek CC, Cheung Tui S. DNA-based diagnosis of thyroid hormone resisitance syndrome. Clinica Chimica Acta. 2005;358:55–9. · DOI
- Maruo Y, Verma IC, Matsui K, Takahashi H, Mimura Y. Conformational change of UGT1A1 by a novel missense mutation (p.L131P) causing Crigler-Najjar syndrome type I. J Pediatr Gastroenterol Nutr. 2008;46:308–11. · DOI
- Anselmo J, Refetoff S. Regression of a large goiter in a patient with resistance to thyroid hormone by every other day treatment with triiodothyronine. Thyroid. 2004;14:71–4. · DOI
- Canadas KT, Rivkees SA, Udelsman R, Breuer CK. Resistance to thyroid hormone associated with a novel mutation of the thyroid β receptor gene in a four-year-old female. Int J Pediatr Endocrinol. 2011;2011:3. · doi:10.1186/1687-9856-2011-3
Cited by
Resistance to thyroid hormone beta: a focused review
Pappa, T., & Refetoff, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.656551 · Cited by 119
Bozorgi, A., Hosseini, H., Eftekhar, H., Majdzadeh, R., Yoonessi, A., Ramezankhani, A., Mansouri, M., & Ashoorkhani, M. (2021) · Trials · doi:10.1186/s13063-021-05270-0 · Cited by 94
Risks and safety of combination therapy for hypothyroidism
Jonklaas, J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1182019 · Cited by 27
Thyroid hormone resistance: mechanisms and therapeutic development
Yao, B., Yang, C., Pan, C., & Li, Y. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111679 · Cited by 26
Metadata
- Authors
- Maruo, Y., Mori, A., Morioka, Y., Sawai, C., Mimura, Y., Matui, K., & Takeuchi, Y.
- Venue
- BMC Endocrine Disorders
- Published
- 2016-01-12
- Volume
- 16
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1472-6823 (ISSN-L)
- OpenAlex
- W2232723683
- Cited by
- 37
- References
- 1
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- the Ministry of Education, Science, and Culture of Japan (15K09710)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report. https://app.cochat.ai/papers/10.1186/s12902-015-0081-7
- The paper
- Maruo, Y., Mori, A., Morioka, Y., Sawai, C., Mimura, Y., Matui, K., & Takeuchi, Y. (2016). Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-015-0081-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.